Ind-Swift Limited – NSE:INDSWFTLTD.NS

Ind-Swift Limited stock price today

INR 13.3
-15.32
-53.55%
Financial Health
0
1
2
3
4
5
6
7
8
9

Ind-Swift Limited stock price monthly change

+50.21%
month

Ind-Swift Limited stock price quarterly change

+50.21%
quarter

Ind-Swift Limited stock price yearly change

+61.30%
year

Ind-Swift Limited key metrics

Market Cap
 1.52B
Enterprise value
 10.64B
P/E
 -1.37
EV/Sales
 2.59
EV/EBITDA
 18.14
Price/Sales
 0.11
Price/Book
 -0.06
PEG ratio
 -0.04
EPS
 2.63
Revenue
 5.02B
EBITDA
 572.95M
Income
 142.31M
Revenue Q/Q
 27.72%
Revenue Y/Y
 22.21%
Profit margin
 -7.92%
Oper. margin
 3.46%
Gross margin
 47.69%
EBIT margin
 3.46%
EBITDA margin
 11.41%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Ind-Swift Limited stock price history

Ind-Swift Limited stock forecast

Ind-Swift Limited financial statements

Profit Margin

Ind-Swift Limited (NSE:INDSWFTLTD.NS): Profit margin
Jun 2023 1.48B 23.62M 1.59%
Sep 2023 1.15B -107.05M -9.24%
Dec 2023 1.02B -149.65M -14.59%
Mar 2024 1.35B 375.39M 27.76%
INDSWFTLTD.NS income statement history

Debt to Assets

Ind-Swift Limited (NSE:INDSWFTLTD.NS): Debt to assets
Jun 2023 0 0
Sep 2023 6390242000 13.52B 211.58%
Dec 2023 0 0
Mar 2024 6544713000 13.45B 205.55%
INDSWFTLTD.NS balance sheet history

Cash Flow

Ind-Swift Limited (NSE:INDSWFTLTD.NS): Cash Flow
Jun 2023 134.42M 0 0
Sep 2023 577.59M -59.04M -502.28M
Dec 2023 135.53M 0 0
Mar 2024 0 0 0
INDSWFTLTD.NS cash flow history

Ind-Swift Limited alternative data

Ind-Swift Limited
Employees

Ind-Swift Limited (NSE:INDSWFTLTD.NS): Employee count
Aug 2023 1,129
Sep 2023 1,129
Oct 2023 1,200
Nov 2023 1,200
Dec 2023 1,200
Jan 2024 1,200
Feb 2024 1,200
Mar 2024 1,200
Apr 2024 1,200
May 2024 1,200
Jun 2024 1,200
Jul 2024 1,200

Ind-Swift Limited other data

Ind-Swift Limited
Executives

Insider Compensation
Dr. Vikrant Rai Mehta (1958) Joint MD & Whole Time Director
 $15,400,000
Dr. Gopal Munjal (1958) Chief Executive Officer, MD & Whole Time Director
 $15,400,000
Mr. Sanjeev Rai Mehta (1956) Executive Chairman
 $15,400,000

Frequently Asked Questions (FAQ)

  • What's the price of Ind-Swift Limited stock today?

    One share of Ind-Swift Limited stock can currently be purchased for approximately $13.3.

  • When is Ind-Swift Limited's next earnings date?

    Unfortunately, Ind-Swift Limited's (INDSWFTLTD.NS) next earnings date is currently unknown.

  • Does Ind-Swift Limited pay dividends?

    No, Ind-Swift Limited does not pay dividends.

  • How much money does Ind-Swift Limited make?

    Ind-Swift Limited has a market capitalization of 1.52B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 26.34% to 5.02B US dollars.

  • What is Ind-Swift Limited's stock symbol?

    Ind-Swift Limited is traded on the NSE under the ticker symbol "INDSWFTLTD.NS".

  • What is Ind-Swift Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Ind-Swift Limited?

    Shares of Ind-Swift Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Ind-Swift Limited's key executives?

    Ind-Swift Limited's management team includes the following people:

    • Dr. Vikrant Rai Mehta Joint MD & Whole Time Director(age: 67, pay: $15,400,000)
    • Dr. Gopal Munjal Chief Executive Officer, MD & Whole Time Director(age: 67, pay: $15,400,000)
    • Mr. Sanjeev Rai Mehta Executive Chairman(age: 69, pay: $15,400,000)

  • How many employees does Ind-Swift Limited have?

    As Jul 2024, Ind-Swift Limited employs 1,200 workers.

  • When Ind-Swift Limited went public?

    Ind-Swift Limited is publicly traded company for more then 20 years since IPO on 18 Oct 2004.

  • What is Ind-Swift Limited's official website?

    The official website for Ind-Swift Limited is indswiftltd.com.

  • How can i contact Ind-Swift Limited?

    Ind-Swift Limited can be reached via phone at +91 172 468 0800.

Ind-Swift Limited company profile:

Ind-Swift Limited

indswiftltd.com
Exchange:

NSE

Full time employees:

1,054

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nutraceuticals, anti-diarrheal, anti-malarial, anti-depressants, cardiology, diabetology, neurology, and oncology. The company also provides contract research and manufacturing services. It serves government dispensaries, doctors, and hospitals through retailers, stockists, and carrying and forwarding channels. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India.

+91 172 468 0800
781, Industrial Area
Chandigarh, 160002

:
ISIN: INE788B01028
CUSIP: Y39908127